Kabra Drugs Ltd — Board Meeting, 01-01-2026: Board Meeting
01-01-2026 | 06:08 pm
01-01-2026 | 06:08 pm
Kabra Drugs Ltd. board approved a name change, in-principle acquisition of Vassmaan Automotive for MedTech & EV components, expansion via 200 new channel partners, and MOA changes to enter EV, Steel, and Solar energy sectors. All subject to shareholder approval.
No comments yet. Be the first to comment!
